Gene · 396
Papers1,898
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 1,898
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic insights into the role of prenyl-binding protein PrBP/δ in membrane dissociation of phosphodiesterase 6. | Nat Commun | 2018 | 29311697 | PubTator, text mining | PubMed |
| Protein phosphatase 1B dephosphorylates Rho guanine nucleotide dissociation inhibitor 1 and suppresses cancer cell migration and invasion. | Cancer Lett | 2018 | 29307615 | PubTator, text mining | PubMed |
| A High-Resolution Proteomic Landscaping of Primary Human Dental Stem Cells: Identification of SHED- and PDLSC-Specific Biomarkers. | Int J Mol Sci | 2018 | 29304003 | PubTator, text mining | PubMed |
| RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPases. | Proc Natl Acad Sci U S A | 2018 | 29279389 | PubTator, text mining | PubMed |
| Omics-Based Platform for Studying Chemical Toxicity Using Stem Cells. | J Proteome Res | 2018 | 29261316 | PubTator, text mining | PubMed |
| Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease. | Biochim Biophys Acta Mol Basis Dis | 2018 | 29246445 | PubTator, text mining | PubMed |
| miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma. | Cancer Res | 2018 | 29229605 | PubTator, text mining | PubMed |
| Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma. | Mol Med Rep | 2018 | 29207103 | PubTator, text mining | PubMed |
| Transcriptomic study of the toxic mechanism triggered by beauvericin in Jurkat cells. | Toxicol Lett | 2018 | 29203277 | PubTator, text mining | PubMed |
| The blood-brain barrier internalises Cryptococcus neoformans via the EphA2-tyrosine kinase receptor. | Cell Microbiol | 2018 | 29197141 | PubTator, text mining | PubMed |
| Sustained Activation of Rho GTPases Promotes a Synthetic Pulmonary Artery Smooth Muscle Cell Phenotype in Neprilysin Null Mice. | Arterioscler Thromb Vasc Biol | 2018 | 29191928 | PubTator, text mining | PubMed |
| Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes. | Diabetologia | 2018 | 29185012 | PubTator, text mining | PubMed |
| Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy. | Mod Pathol | 2018 | 29148534 | PubTator, text mining | PubMed |
| Top-down characterization of endogenous protein complexes with native proteomics. | Nat Chem Biol | 2018 | 29131144 | PubTator, text mining | PubMed |
| Transcriptional inhibition of TCDD-mediated induction of cytochrome P450 1A1 and alteration of protein expression in a zebrafish hepatic cell line following the administration of TCDD and Cd2. | Toxicol Lett | 2018 | 29107029 | PubTator, text mining | PubMed |
| EphrinB1 promotes cancer cell migration and invasion through the interaction with RhoGDI1. | Oncogene | 2018 | 29059157 | PubTator, text mining | PubMed |
| Metastasis suppressors: functional pathways. | Lab Invest | 2018 | 28967874 | PubTator, text mining | PubMed |
| Rho-inhibiting C2IN-C3 fusion toxin inhibits chemotactic recruitment of human monocytes ex vivo and in mice in vivo. | Arch Toxicol | 2018 | 28924833 | PubTator, text mining | PubMed |
| Ezrin Orchestrates Signal Transduction in Airway Cells. | Rev Physiol Biochem Pharmacol | 2018 | 28702704 | PubTator, text mining | PubMed |
| Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors. | Small GTPases | 2018 | 27548350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/396/papers?page=41